Line-item BOM across 20 unique sub-assemblies
10,000
0
From design transfer to first product shipment
5 Months
0
Case Study
Scaling a cGMP Cell Therapy Manufacturing Platform from Prototype to Clinical Production
From Design Transfer to First Shipment in 5 Months, Earning FDA Advanced Manufacturing Technology Designation
A fast-growing cell therapy company needed to transition a fully integrated, cGMP-compliant CAR-T manufacturing platform from laboratory prototype to low-volume production in preparation for clinical trial deployment. Ascential assumed turn-key manufacturing responsibility and delivered the first completed instrument within 5 months of design transfer. The platform subsequently earned FDA Advanced Manufacturing Technology (AMT) designation.
The Challenge
Scaling a cGMP cell therapy manufacturing platform from prototype to production-ready instrument is among the most demanding programs in life sciences manufacturing. These systems must execute automated, end-to-end workflows including cell enrichment, selection, transduction, transfection, activation, expansion, and formulation, all while meeting rigorous in-process and final product specifications.
The client faced three compounding challenges:
Build Production Infrastructure from Scratch
Develop assembly procedures, test protocols, and production infrastructure without an established baseline, transitioning directly from a lab prototype.
Manage Design Changes in an Active Production Environment
Source and track components across 20 sub-assemblies while resolving documentation gaps and manufacturability issues in parallel with ongoing builds.
Enable Global Delivery of 12,000-pound Instruments
Design packaging and shipping infrastructure capable of supporting safe ocean freight delivery to clinical and commercial sites worldwide.
Ascential's Solution
Ascential engaged as a turn-key manufacturing partner, taking full ownership from design transfer through final shipment. Rather than waiting for stabilized documentation or a settled BOM, the team created production processes in parallel with ongoing design evolution, establishing assembly and test procedures from the ground up.
By partnering closely with the client engineering team and owning resolution of production issues in real time, Ascential maintained quality and schedule continuity throughout a highly dynamic development-to-production transition.
As documentation gaps and manufacturability issues surfaced, Ascential corrected them without interrupting production. Where field issues emerged post-deployment, key subsystems were redesigned to improve performance. To support global distribution, Ascential developed a dedicated packaging and logistics solution capable of protecting 12,000-pound instruments through ocean freight delivery.
Technical Capabilities Delivered
| Capability | What Ascential Built |
|---|---|
| Assembly and Test Procedures | Developed comprehensive assembly and test procedures from scratch using deep product expertise to support complex instrument builds |
| BOM Management | Loaded, sourced, and managed a 10,000-line BOM with 20 unique sub-assemblies across the full production lifecycle |
| Design Documentation Remediation | Identified and corrected gaps in design documentation and component manufacturability to ensure production-ready builds |
| Subsystem Redesign | Redesigned key subsystems to resolve field issues and improve performance with minimal disruption to active production |
| Production Issue Resolution | Partnered directly with the client engineering team to diagnose and resolve production issues while maintaining quality and schedule |
| Packaging and Logistics Engineering | Engineered packaging and shipping infrastructure capable of supporting ocean delivery of 12,000-pound instruments to global destinations |
Key Results
- First instrument shipped in 5 months, meeting clinical trial deployment timelines despite a complex, evolving production environment.
- FDA Advanced Manufacturing Technology (AMT) designation achieved, recognizing the platform’s technical rigor and manufacturing quality.
- Instruments deployed in clinical-stage pharmaceutical collaborations supporting early-stage CAR-T cell therapy development programs.
- Production continuity maintained throughout active design changes, with documentation and manufacturability issues resolved without disrupting builds.
- Global logistics infrastructure commissioned, enabling ocean delivery of large-format instruments to clinical and commercial sites worldwide.
Why It Matters
CAR-T and other advanced cell therapies are among the most promising treatment options for patients with limited alternatives in oncology and rare disease. Their clinical potential depends on manufacturing systems that can perform reliably at scale. Compressing the timeline from prototype to production-ready instrument, under cGMP requirements and within clinical deadlines, requires a partner capable of absorbing complexity across engineering, procurement, documentation, and logistics simultaneously.
For the client, Ascential’s turn-key ownership protected clinical trial timelines and positioned the platform for commercial scale from the outset. For patients, faster instrument deployment translates directly into faster access to investigational therapies.
Your Life-Saving Product Requires Precision Manufacturing
Curious about how quickly Ascential can scale your complex development and production workflows? Let’s solve your biggest design, automation, or manufacturing challenge.
Get Your 15-Minute Consultation